Dr Dionysis Papadatos-Pastos | London Lung Oncologist

I am a London based oncologist, specialist in the treatment of lung cancer, mesothelioma and thymic tumors.

Conditions treated

Comprehensive thoracic cancer treatment

Testimonials

What Our Patients Are Saying

Clinics

Harley Street & Chelsea

View
Immunotherapy in NSCLC

Immunotherapy has transformed the treatment landscape for non-small cell lung cancer (NSCLC), offering new hope,...

Advanced stage small cell lung cancer

Extensive-stage small cell lung cancer (SCLC) is a challenging diagnosis, as it indicates the cancer...

Targeted therapies in NSCLC

Targeted therapies have revolutionized the treatment of non-small cell lung cancer (NSCLC), offering more personalized...

Understanding ALK-Driven Non-Small Cell Lung Cancer (NSCLC)

Anaplastic Lymphoma Kinase (ALK)-driven non-small cell lung cancer (NSCLC) is a subtype of lung cancer...

Early stage small cell lung cancer

The treatment of early-stage small cell lung cancer (SCLC) has traditionally involved a combination of...

Treatment of ROS1-Driven Lung Cancer: A Comprehensive Overview

Lung cancer remains one of the most common and lethal cancers worldwide, but advances in...

Clinical trials

Clinical trials are crucial in advancing lung cancer treatment, offering patients access to cutting-edge therapies...

Why surgery should not be routinely used in patients with mesothelioma

The MARS2 trial (Mesothelioma and Radical Surgery 2) was designed to evaluate the effectiveness of...

Recent Advances in the Treatment of EGFR (common mutations)-Driven Non-Small Cell Lung Cancer (NSCLC)

Lung cancer is one of the most common and deadliest cancers worldwide, and about 85%...

Newspapers And Media

Media

Dr Papadatos-Pastos in the Evening Standard (10 September 2024)

Hopeful horizons for lung cancer patients As seen in the Evening Standard newspaper on September...